Navigation Links
More Findings on Gene Involved in Childhood Asthma
Date:9/15/2008

PHILADELPHIA, Sept. 15 /PRNewswire-USNewswire/ -- Asthma researchers have found that a gene variant known to raise the risk of childhood asthma in European children plays a similar role in white American children, but not in African American children.

The most common chronic illness among children in the developed world, asthma is a complex disease in which a variety of genes are thought to interact with each other and with environmental influences to produce its effects. As in many other genetic diseases, researchers expect that better knowledge of gene associations will pave the way for new treatments and to customizing treatments to each patient's genetic profile.

Researchers from The Children's Hospital of Philadelphia found that variants in the ORMDL3 gene were associated with childhood-onset asthma among U.S. patients of European ancestry. In 2007 a study team based in Europe had identified the ORMDL3 gene, located on chromosome 17, as contributing to childhood asthma among British and German children.

The current study, from The Children's Hospital of Philadelphia and the University of Pennsylvania School of Medicine, appeared as a brief online report Aug. 29 in the Journal of Allergy and Clinical Immunology.

"We replicated the European findings among American children, and showed that the gene plays a role in asthma of any severity level," said study leader and pediatric pulmonologist Hakon Hakonarson, M.D., Ph.D., director of the Center for Applied Genomics at Children's Hospital. "The previous group had detected the association of ORMDL3 with asthma by examining families having two or three members with severe disease."

Furthermore, said Hakonarson, "Through the testing of additional markers, our data suggest that other genes outside the region occupied by ORMDL3 might have important roles in raising susceptibility to asthma." His group plans further studies to further refine this and other regions.

Drawing on patients from the Children's Hospital network, the study team analyzed DNA from 807 white children with asthma, compared to 2,583 white children without the disease. Another cohort consisted of African American children, of whom 1,456 had asthma and 1,973 were healthy controls. The researchers used highly automated gene-scanning equipment at Children's Hospital's Center for Applied Genomics, the largest pediatric genotyping program in the world.

"Because asthma is a very heterogeneous disease, the genes involved in childhood-onset asthma may be very different from those involved in asthma that first appears in adults," said Hakonarson. "Furthermore, the biological mechanisms by which genetic variants contribute to asthma are not well understood. However, we will continue our investigations, to shed light on how we might use genetic knowledge to develop more effective treatments for this common disease. These treatments will be a form of personalized medicine, better tailored to the genetic makeup of the individual patient."

An Institute Development Award from The Children's Hospital of Philadelphia supported this research. Hakonarson's co-authors, all from Children's Hospital, included Patrick M.A. Sleiman, Ph.D., Julian Allen, M.D., Jonathan Spergel, M.D., Ph.D., Robert Grundmeier, M.D., Ph.D., Michael M. Grunstein, M.D., Ph.D., and Mark Magnusson, M.D. Hans Bisgaard, M.D., from the University of Copenhagen, Denmark, also collaborated.

About The Children's Hospital of Philadelphia: The Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country, ranking third in National Institutes of Health funding. In addition, its unique family-centered care and public service programs have brought the 430-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu.

Contact: John Ascenzi

Phone: (267) 426-6055

Ascenzi@email.chop.edu


'/>"/>
SOURCE The Children's Hospital of Philadelphia
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Interleukin Genetics to Present Important New Findings at 2008 World Congress on Osteoarthritis
2. VAI Findings Could Aid Diagnosis and Treatment of Several Types of Kidney Cancer
3. Findings on Bladder-Brain Link May Point to Better Treatments for Problems in Sleep, Attention
4. Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
5. FDA Updates Label for AVANDIA(R) to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years
6. Tengion Scientists Publish Key Preclinical Findings Demonstrating the Benefits of Organ Regeneration Vs. Repair
7. Study Findings Show Infection Control Intervention Helps Keep Kids in School
8. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
9. ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
10. ACORN Presents Findings of Collaborative Metastatic Colorectal Cancer Research
11. Halozyme Therapeutics Presents Findings on Combinations of rHuPH20 Enzyme With Bisphosphonates at the American Association for Cancer Research Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... May 4, 2016 Yissum ... announced today that it had signed an exclusive ... , developer of novel protein degradation and immunomodulatory drugs ... commercialization of drug candidates representing first-in-class therapy for hematologic ... not disclosed. The novel technology was developed ...
(Date:5/4/2016)... 2016 Valeritas Holdings, Inc. (OTCQB: ... public offering (APO). This was accomplished via a reverse ... and a private placement of approximately 5 million shares ... Under the terms of the reverse merger, ... Inc. will trade on the OTC Markets under the ...
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Acute Ischemic Stroke ...  report to their offering.       ... Global Acute Ischemic Stroke Market and ... into Acute Ischemic Stroke pipeline products, Acute ...
Breaking Medicine Technology:
(Date:5/4/2016)... Providence, Rhode Island (PRWEB) , ... May 04, ... ... was launched in April 2016. SS&A teamed up with one of the top ... This legal information portal contains informative legal articles related to the law firm's ...
(Date:5/4/2016)... ... May 04, 2016 , ... Francesca Loparco, Co-Founder of ... life forever with a same-day LASIK procedure at Christenbury Eye Center. The ... Jonathan Christenbury performed her surgery the same day as her in-office consultation and eye ...
(Date:5/4/2016)... ... May 04, 2016 , ... Advanced Spine & Sport Medical Rehabilitation Center, which ... is hosting a free seminar on stem cell injections. The seminar is scheduled for ... Sport, 4601 Telephone Road, Suite 110, Ventura, CA. There are only 10 seats available. ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... powerful cellular therapy software application that helps blood and marrow transplant (BMT) programs ... Transtem’s initial launch, Mediware has continued to enhance core application features. These enhancements ...
(Date:5/4/2016)... ... May 04, 2016 , ... International Conference on Obesity ... 25-27, 2016 at Las Vegas. It aims to bring together academicians, scientists, dietitians, ... research organizations across the globe; making the conference a perfect platform to share ...
Breaking Medicine News(10 mins):